BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Newron Pharmaceuticals 

Via R. Lepetit
21040
Gerenzano      Italy
Phone: 39-02-9668131 Fax: 39-02-96681333


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Newron Pharmaceuticals (NWRN) Release: New Results With NW-3509 Presented At SIRS Conference 4/8/2014 4:08:51 PM    More...
Newron Pharmaceuticals (NWRN) Release: Safinamide Application For Authorization Submitted To Swissmedic 4/7/2014 4:04:26 PM    More...
Newron Pharmaceuticals (NWRN) Raises CHF18.6 Million In Private Placement To Existing And New Institutional Shareholders In Europe And The U.S. 4/7/2014 3:35:54 PM    More...
Newron Pharmaceuticals (NWRN) Reports 2013 Financial Results Board Approves Agenda For March 27 AGM/EGM Change In Board Of Directors 3/4/2014 9:05:00 AM    More...
Newron Pharmaceuticals (NWRN) Release: Safinamide Marketing Authorization Application (MAA) Submitted To The European Medicines Agency 12/5/2013 10:54:12 AM    More...
Newron Pharmaceuticals (NWRN) Reports Half-Year Results 2013 9/10/2013 12:27:13 PM    More...
Newron Pharmaceuticals (NWRN) Release: Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6/19/2013 10:17:21 AM    More...
Newron Pharmaceuticals (NWRN) Puts Top Drug at Risk in NeuroNova AB Deal, Shareholder Says 9/14/2012 7:43:50 AM    More...
Newron Pharmaceuticals (NWRN) Snags NeuroNova AB for About $19.3 Million in Shares for Clinical ALS and Parkinson Disease Drugs 6/13/2012 7:13:53 AM    More...
Newron Pharmaceuticals (NWRN) PD Drug Succeeds in Phase III, $26 Million Zambon Pact Sealed 5/16/2012 7:49:13 AM    More...
12345678

//-->